Resolutions from Annual General Meeting in NeuroVive Pharmaceutical AB (publ)
(WorldNews Sweden)

Lund, Sweden, 27 April 2017 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) ("NeuroVive")today on 27 April 2017 held its Annual General Meeting (AGM). A description of the resolutions follows. All resolutions were passed with the required majority. Approval of profit and loss accounts and balance sheets, and discharge from liability of the board members and the managing director The profit and loss account and balance sheets were approved, and the managing director and the board members were discharged from liability with respect to their respective management of the company for financial year 2016. Dividend In accordance with the Board of Directors` proposal, it...